Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,09 USD | -2,48% | +0,88% | -19,06% |
Omzet 2024 * | 24,87 mln. 31,43 mln. 29,12 mln. | Omzet 2025 * | 118 mln. 149 mln. 138 mln. | Marktkapitalisatie | 1,03 mld. 1,3 mld. 1,21 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -75 mln. -94,77 mln. -87,79 mln. | Nettowinst (verlies) 2025 * | -24 mln. -30,33 mln. -28,09 mln. | EV/omzet 2024 * | 34 x |
Nettoliquiditeiten 2024 * | 184 mln. 232 mln. 215 mln. | Nettoliquiditeiten 2025 * | 146 mln. 185 mln. 171 mln. | EV/omzet 2025 * | 7,5 x |
K/w-verhouding 2024 * |
-27,3
x | K/w-verhouding 2025 * |
-97,5
x | Werknemers | 79 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 75,42% |
Recentste transcriptie over Verona Pharma plc
1 dag | -2,48% | ||
1 week | +0,88% | ||
Lopende maand | -6,56% | ||
1 maand | -6,78% | ||
3 maanden | -20,19% | ||
6 maanden | -2,60% | ||
Lopend jaar | -19,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-02-20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01-03-20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17-06-16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12-09-16 |
David Ebsworth
CHM | Chairman | 69 | 01-12-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.09% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 16,09 | -2,48% | 309 349 |
27-03-24 | 16,5 | +2,23% | 359 388 |
26-03-24 | 16,14 | +2,74% | 397 379 |
25-03-24 | 15,71 | -2,24% | 294 308 |
22-03-24 | 16,07 | +0,75% | 364 289 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,06% | 1,3 mld. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-36,53% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |